These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 2422490

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Physiological effects of short-term treatment with enalapril in hypertensive patients.
    de Leeuw PW, Hoogma RP, van Soest GA, van Es PN, Birkenhäger WH.
    J Hypertens Suppl; 1983 Oct; 1(1):87-91. PubMed ID: 6100612
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA, Marcó E, Gilbert HB, Raffaele P, Brito M, Giménez M, Moledo LI.
    Drugs; 1985 Oct; 30 Suppl 1():49-58. PubMed ID: 2994987
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
    Nussberger J, Wuerzner G, Jensen C, Brunner HR.
    Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102
    [Abstract] [Full Text] [Related]

  • 7. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G, Cottone S, D'Ignoto G, Grasso L, Carone MB, Carapelle E, Contorno A.
    Clin Ther; 1987 Jan; 9(4):390-9. PubMed ID: 3038326
    [Abstract] [Full Text] [Related]

  • 8. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension.
    van den Meiracker AH, Admiraal PJ, Derkx FH, Kleinbloesem C, Man in 't Veld AJ, van Brummelen P, Mulder P, Schalekamp MA.
    J Hypertens; 1993 Aug; 11(8):831-8. PubMed ID: 8228207
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
    Redgrave J, Rabinowe S, Hollenberg NK, Williams GH.
    J Clin Invest; 1985 Apr; 75(4):1285-90. PubMed ID: 2985655
    [Abstract] [Full Text] [Related]

  • 12. Renal and endocrine effects of long-term converting enzyme inhibition as compared with calcium antagonism in essential hypertension.
    Katzman PL, Henningsen NC, Fagher B, Thulin T, Hulthén UL.
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):360-4. PubMed ID: 1691357
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prolonged converting enzyme inhibition in non-modulating hypertension.
    Dluhy RG, Smith K, Taylor T, Hollenberg NK, Williams GH.
    Hypertension; 1989 Apr; 13(4):371-7. PubMed ID: 2538393
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Renal and endocrine response to saline infusion in essential hypertension.
    Rydstedt LL, Williams GH, Hollenberg NK.
    Hypertension; 1986 Mar; 8(3):217-22. PubMed ID: 3005169
    [Abstract] [Full Text] [Related]

  • 17. [The acute effects of the new angiotensin I-converting enzyme inhibitor, enalapril maleate, on blood pressure, plasma renin, aldosterone and kinins in hypertensive patients].
    Gotoh M, Mizuno K, Hashimoto S, Kunii N, Fukuchi S.
    Nihon Naibunpi Gakkai Zasshi; 1985 May 20; 61(5):619-29. PubMed ID: 2991035
    [Abstract] [Full Text] [Related]

  • 18. Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-aldosterone system.
    Reams GP, Bauer JH, Gaddy P.
    Hypertension; 1986 Apr 20; 8(4):290-7. PubMed ID: 3007351
    [Abstract] [Full Text] [Related]

  • 19. Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects.
    Reams GP, Lal SM, Whalen JJ, Bauer JH.
    J Clin Hypertens; 1986 Sep 20; 2(3):245-53. PubMed ID: 3023555
    [Abstract] [Full Text] [Related]

  • 20. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J, Henik RA, Brownfield M, Armstrong J.
    Am J Vet Res; 1997 May 20; 58(5):535-40. PubMed ID: 9140564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.